TOVX
TOVX
AMEX · Biotechnology

Theriva Biologics Inc

$0.22
+0.02 (+10.06%)
As of Feb 8, 2:30 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.03M 1.08M 955.9K
Net Income -22,361 -31,787 -25,174
EPS
Profit Margin -2.2% -2.9% -2.6%
Rev Growth +0.6% -3.8% +4.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.39M 2.56M 2.46M
Total Equity 2.86M 2.77M 2.86M
D/E Ratio 0.84 0.93 0.86
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -38,355 -35,389 -33,870
Free Cash Flow -18,843 -19,077 -22,857